Levonadifloxacin clinical trials
Also written WCK 2349.
How each study uses levonadifloxacin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- WCK 2349
- 3
Studies by the year they started
6 studies that test it; most in 2014 (3)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 3 |
| 2017 | 1 |
Who runs them
Industry 6 · Other 0
Often tested with
Tested in the same studies.
WCK 771 (1)
Studies
Open first, then newest update. How each study uses levonadifloxacin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Oral WCK 2349CompletedPhase 1WockhardtNCT04874324Written as WCK 2349 OralHow we know
- Comparative Study of Levonadifloxacin (IV and Oral) With Linezolid (IV and Oral) in Acute Bacterial Skin and Skin Structure Infections (ABSSSI)CompletedPhase 3WockhardtNCT03405064Written as Oral Levonadifloxacin/Linezolid TabletHow we know
- Pharmacokinetics of WCK 2349 In Patients With Hepatic ImpairmentCompletedPhase 1WockhardtNCT02244827Written as WCK 2349How we know
- Study to Evaluate the Effect Of WCK 2349 on the QT/QTc Interval in Health VolunteersCompletedPhase 1WockhardtNCT02217930Written as WCK 2349How we know
- Study to Determine and Compare Plasma and Intrapulmonary Pharmacokinetics of WCK 2349 in Healthy Adult Human SubjectsCompletedPhase 1WockhardtNCT02253342Written as WCK-2349How we know
- Phase I, Open Label,Crossover Food-Effect and Absolute Bioavailability Study of WCK2349 and WCK771 in Healthy Adult Human VolunteersCompletedPhase 1WockhardtNCT01875939Written as Oral WCK2349How we know
Codes
What other systems call levonadifloxacin · ClinicalTrials.gg INT001319
- MeSH (NLM) C000706771levonadifloxacinConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 8WHH66L098LEVONADIFLOXACINConfirmed FDA, NLM, Wikidata
- Wikidata Q27117310levonadifloxacinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C83879LevonadifloxacinOne source FDA
- DrugBank DB16219One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000706771 | levonadifloxacin | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 8WHH66L098 | LEVONADIFLOXACIN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27117310 | levonadifloxacin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C83879 | Levonadifloxacin | One source FDA |
| DrugBank | DB16219 | — | One source Wikidata |
Also registered as alalevonadifloxacin (UNII 57B7E1D1TG).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.